We are live on
!
Find out more
ACM
Atlanta Capital Management Portfolio holdings
AUM
$22.5B
1-Year Est. Return
9.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
-9.67%
3 Year Est. Return
+30.19%
5 Year Est. Return
+88.74%
10 Year Est. Return
–
AUM
$14.5B
AUM Growth
-$727M
(-4.8%)
Cap. Flow
-$555M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
18.56%
Holding
205
New
10
Increased
58
Reduced
111
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$114M |
| 2 |
WFM
Whole Foods Market Inc
WFM
|
+$59.4M |
| 3 |
PX
Praxair Inc
PX
|
+$47M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$44.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$76.8M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$50.3M |
| 3 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$47.4M |
| 4 |
Acuity Brands
AYI
|
+$46.3M |
| 5 |
GE Aerospace
GE
|
+$43.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.61% |
| 2 | Financials | 18.39% |
| 3 | Healthcare | 15.99% |
| 4 | Consumer Discretionary | 15.49% |
| 5 | Technology | 12.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Markel Group
MKL
$25B
| $361M | 2.49% |
606,082
-7,780
| -1% | -$4.43M |
|
2
Morningstar
MORN
$6.56B
| $336M | 2.31% |
4,246,617
-6,290
| -0.1% | -$501K |
|
3
Affiliated Managers Group
AMG
$9.46B
| $273M | 1.88% |
1,363,889
+7,182
| +0.5% | +$1.41M |
|
4
Kirby Corp
KEX
$7.95B
| $270M | 1.86% |
2,661,725
-105,557
| -4% | -$10.6M |
|
|
HCC
5
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $269M | 1.86% |
5,924,286
+239,303
| +4% | +$10.6M |
|
6
LKQ Corp
LKQ
$6.58B
| $247M | 1.7% |
9,373,479
-26,764
| -0.3% | -$749K |
|
7
Sally Beauty Holdings
SBH
$1.4B
| $244M | 1.68% |
8,919,278
-47,214
| -0.5% | -$1.35M |
|
8
Apple
AAPL
$4.89T
| $234M | 1.61% |
12,182,352
-2,276,288
| -16% | -$43.3M |
|
9
Alphabet (Google) Class C
GOOG
$3.9T
| $232M | 1.6% |
8,352,430
-1,200,844
| -13% | -$35M |
|
10
Bio-Rad Laboratories Class A
BIO
$8.42B
| $231M | 1.59% |
1,800,328
-9,660
| -0.5% | -$1.24M |
|
11
Dentsply Sirona
XRAY
$2.59B
| $228M | 1.57% |
4,962,923
+293,006
| +6% | +$13.6M |
|
|
12
Acuity Brands
AYI
$9.88B
| $226M | 1.56% |
1,708,417
-350,167
| -17% | -$46.3M |
|
13
Henry Schein
HSIC
$9.74B
| $217M | 1.5% |
4,643,614
-23,697
| -0.5% | -$1.08M |
|
|
CYN
14
DELISTED
CITY NATIONAL CORPORATION
CYN
| $212M | 1.46% |
2,698,462
+258,078
| +11% | +$19.4M |
|
15
Qualcomm
QCOM
$176B
| $204M | 1.41% |
2,588,404
-305,689
| -11% | -$23M |
|
16
CVS Health
CVS
$137B
| $200M | 1.38% |
2,672,142
-505,391
| -16% | -$35.7M |
|
17
Fair Isaac
FICO
$28.7B
| $200M | 1.37% |
3,608,608
-13,298
| -0.4% | -$735K |
|
18
Carlisle Companies
CSL
$13.6B
| $198M | 1.37% |
2,501,631
-46,401
| -2% | -$3.61M |
|
|
ANSS
19
DELISTED
Ansys
ANSS
| $192M | 1.32% |
2,493,131
+340,854
| +16% | +$27.6M |
|
20
AptarGroup
ATR
$8.45B
| $185M | 1.27% |
2,798,882
-10,731
| -0.4% | -$699K |
|
21
IDEX
IEX
$16.5B
| $183M | 1.26% |
2,513,986
-40,116
| -2% | -$2.92M |
|
22
Gilead Sciences
GILD
$161B
| $183M | 1.26% |
2,583,626
-123,116
| -5% | -$9.66M |
|
|
CLC
23
DELISTED
Clarcor
CLC
| $170M | 1.17% |
2,956,039
+2,333
| +0.1% | +$135K |
|
24
Blackbaud
BLKB
$1.5B
| $163M | 1.13% |
5,222,737
+185,183
| +4% | +$6.23M |
|
25
Equifax
EFX
$20.3B
| $163M | 1.12% |
2,394,667
-18,852
| -0.8% | -$1.32M |
|
Similar funds
JG
AII
MFRM
MA
5L
RC
W
APA
Atlanta Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Atlanta Capital Management held 205 positions worth $14.5B, down 4.8% from $15.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Atlanta Capital Management withdrew a net $555M in Q1 2014, closing 7 positions and reducing 111 holdings. Its most notable exit was Middleby, an estimated $28.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Atlanta Capital Management opened a new position in Perrigo worth $112M.
- Atlanta Capital Management's largest Q1 2014 buy was Perrigo: 722,229 shares worth $112M.
- Atlanta Capital Management added most to Praxair Inc in Q1 2014, an estimated $47M increase.
- Atlanta Capital Management's biggest Q1 2014 reduction was Microsoft, cutting an estimated $76.8M.
- Atlanta Capital Management fully exited Middleby in Q1 2014, selling an estimated $28.7M.
- Atlanta Capital Management's ten largest holdings make up 19% of its $14.5B portfolio in Q1 2014.
- Atlanta Capital Management opened 10 new positions and closed 7 in Q1 2014.
- Atlanta Capital Management's portfolio value fell 4.8% quarter-over-quarter to $14.5B.
Based on Atlanta Capital Management's 13F filing for Q1 2014, filed 14 May 2014.